Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.10%	Cream	215,015 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.10%	Emulsion	177,387 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.10%	Emulsion	177,387 L.L
A10AE04	LANTUS SOLOSTAR	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	4,992,375 L.L
A10AE04	LANTUS	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	3,327,354 L.L
C07AG01	LABETALOL HYDROCHLORIDE INJECTION	G	Labetalol HCl - 100mg/20ml	100mg/20ml	Injectable solution	2,955,110 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 100mg	100mg	Tablet	4,856,647 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 200mg	200mg	Tablet	8,284,105 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 50mg	50mg	Tablet	614,136 L.L
J05AF05	LAMIVUDINE ARROW	G	Lamivudine - 150mg	150mg	Tablet, coated, scored	7,850,907 L.L
J05AR01	LAMIVUDINE/ ZIDOVUDINE ARROW	G	Lamivudine - 150mg, Zidovudine - 300mg		Tablet, coated, scored	15,643,319 L.L
J05AF05	LAMIVUDINE ARROW	G	Lamivudine - 300mg	300mg	Tablet, coated	7,850,907 L.L
N03AX09	LAMOTRIGINE ARROW LAB	G	Lamotrigine - 100mg	100mg	Tablet, dispersible/ chewable	1,050,885 L.L
N03AX09	LAMOTRIGINE BIOGARAN	G	Lamotrigine - 100mg	100mg	Tablet, dispersible	1,233,647 L.L
N03AX09	LAMOTRIGINE NORMON	G	Lamotrigine - 100mg	100mg	Tablet, dispersible/ chewable	2,284,532 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 100mg	100mg	Tablet	2,741,209 L.L
N03AX09	LEPIGINE	G	Lamotrigine - 100mg	100mg	Tablet, scored	1,163,768 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 25mg	25mg	Tablet	1,088,270 L.L
N03AX09	LAMOTRIGINE ARROW LAB	G	Lamotrigine - 25mg	25mg	Tablet, dispersible/ chewable	556,351 L.L
N03AX09	LAMOTRIGINE BIOGARAN	G	Lamotrigine - 25mg	25mg	Tablet, dispersible	595,322 L.L
N03AX09	LAMOTRIGINE ARROW LAB	G	Lamotrigine - 50mg	50mg	Tablet, dispersible/ chewable	1,052,229 L.L
N03AX09	LAMOTRIGINE BIOGARAN	G	Lamotrigine - 50mg	50mg	Tablet, dispersible	985,037 L.L
N03AX09	LAMOTRIGINE NORMON	G	Lamotrigine - 50mg	50mg	Tablet, dispersible/ chewable	1,643,519 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 50mg	50mg	Tablet	1,753,895 L.L
N03AX09	LAMICTAL LIQUI-TABS	B	Lamotrigine - 5mg	5mg	Tablet	361,046 L.L
A02BC03	LPZ-30	G	Lansoprazole - 30mg	30mg	Capsule, delayed release	360,150 L.L
L04AX04	LENOMA	G	Lenalidomide - 10mg	10mg	Capsule, hard	L.L
L04AX04	LEDOBOOK 10	G	Lenalidomide - 10mg	10mg	Capsule	62,230,245 L.L
L04AX04	LENALIDOMIDE ARROW	G	Lenalidomide - 10mg	10mg	Capsule	26,651,802 L.L
L04AX04	LENALIDOMIDE NEAPOLIS	G	Lenalidomide - 10mg	10mg	Capsule	72,248,183 L.L

...